A 19-year-old woman with a history of depression and anxiety symptoms was admitted to the hospital because of seizure, ...

The company plans to direct resources away from a drug developed by subsidiary Recognify Life Sciences and toward Atai’s ...

The trial failed to achieve statistical significance in its goal of improved MCCB neurocognitive composite scores.

Initial results demonstrate numerical improvement of cognitive and functional measures with inidascamine across both active ...

Nonmodifiable risk factors for DLB include age and family history. Risk increases substantially in individuals with a ...

Mental illness cost Imtiaz Zafar almost a decade of his academic life. Now it motivates him to help find effective treatments ...

--Evoke Pharma, Inc., a specialty pharmaceutical company focused primarily on treatments for gastrointestinal diseases with an emphasis on GIMOTI ® nasal spray, today announced that it has ...

Loxapine may be effective for the treatment of schizophrenia but does not differ greatly from the older typical antipsychotics (chlorpromazine, trifluperazine, perphenazine) or other atypicals ...